EP3888674
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
:
EP einkaleyfi: Þýðing ekki lögð inn:
7.4.2015:
3.4.2024:
21160203.2
:
6.4.2035
:
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
7.4.2015
3.4.2024
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
The Trustees of The University of Pennsylvania:
3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104, US
:
BYRD, John:
Columbus, OH 43212, US
:
DUBOVSKY, Jason:
Columbus, OH 43235, US
:
FRAIETTA, Joseph:
Cherry Hill, NJ 08002, US
:
GILL, Saar:
Philadelphia, PA 19106, US
:
GLASS, David:
Cambridge, MA 02139, US
:
JOHNSON, Amy:
Dublin, OH 43016, US
:
JUNE, Carl H.:
Merion Station, PA 19066, US
:
KENDERIAN, Saad:
Philadelphia, PA 19146, US
:
MANNICK, Joan:
Cambridge, MA 02139, US
:
MAUS, Marcela:
Bryn Mawr, PA 19010, US
:
MURPHY, Leon:
Cambridge, MA 02139, US
:
MUTHUSAMY, Natarajan:
Galloway, OH 43119, US
:
PORTER, David L.:
Springfield, PA 19064, US
:
RUELLA, Marco:
Philadelphia, PA 19143, US
:
SELLERS, William Raj:
Cambridge, MA 02139, US
:
WASIK, Mariusz:
Ardmore, PA 19003, US
:
BROGDON, Jennifer:
Cambridge, MA 02139, US
:
201461976396 P:
7.4.2014:
US
:
201462007309 P:
3.6.2014:
US
:
201462036493 P:
12.8.2014:
US
:
201462076238 P:
6.11.2014:
US
:
201462087888 P:
5.12.2014:
US
:
201462097278 P:
29.12.2014:
US
:
A61K 39/00, A61K 35/17, A61K 31/436, A61P 35/02